Thomas Elebring
Impact in
- Pharmacology top 0.5%
- Cannabis and Cannabinoid Research
-
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
Papers in
-
- Neurotransmitter Receptor Influence on Behavior 6
-
- Gastroesophageal reflux and treatments 4
- Co-authors
- Peter J. Greasley (3 shared papers)Erik Ryberg (2 shared papers)Niklas Larsson (2 shared papers)Stephan Hjorth (2 shared papers)S. Sjögren (1 shared paper)Tomáš Drmota (1 shared paper)Peter M Nilsson (2 shared papers)Sverker von Unge (5 shared papers)
- Journals
- Journal of Medicinal Chemistry (8 papers)British Journal of Pharmacology (3 papers)The Journal of Organic Chemistry (2 papers)Drug Discovery Today (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Thomas Elebring
25 papers receiving 2.1k citations
Thomas Elebring's Hit Papers
Peers
Comparison fields: 5 of 116
- Pharmacology 1.3k
- Cellular and Molecular Neuroscience 659
- Toxicology 69
- Endocrine and Autonomic Systems 116
- Biological Psychiatry 35
Countries citing papers authored by Thomas Elebring
This map shows the geographic impact of Thomas Elebring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Elebring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Elebring more than expected).
Fields of papers citing papers by Thomas Elebring
This network shows the impact of papers produced by Thomas Elebring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Elebring. The network helps show where Thomas Elebring may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Elebring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The orphan receptor GPR55 is a novel cannabinoid receptor Hit paper breakdown → | 2007 | 1329 |
| 2 | 2000 | 217 | |
| 3 | 2004 | 121 | |
| 4 | 1991 | 65 | |
| 5 | 2007 | 60 | |
| 6 | 2009 | 58 | |
| 7 | 2011 | 52 | |
| 8 | 2009 | 46 | |
| 9 | 2008 | 43 | |
| 10 | 2002 | 40 | |
| 11 | 1987 | 17 | |
| 12 | 1982 | 17 | |
| 13 | 2012 | 16 | |
| 14 | 1993 | 13 | |
| 15 | 2007 | 12 | |
| 16 | 1994 | 12 | |
| 17 | 2008 | 9 | |
| 18 | 1988 | 9 | |
| 19 | 2005 | 9 | |
| 20 | 1985 | 9 |
About Thomas Elebring
Thomas Elebring is a scholar working on Cellular and Molecular Neuroscience, Gastroenterology, Organic Chemistry, Speech and Hearing and Computational Theory and Mathematics, having authored 25 papers that have together received 2.2k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (6 papers), Computational Drug Discovery Methods (4 papers), Gastroesophageal reflux and treatments (4 papers), Cannabis and Cannabinoid Research (3 papers), Dysphagia Assessment and Management (3 papers), Analytical Chemistry and Chromatography (3 papers), Pharmacological Receptor Mechanisms and Effects (3 papers) and Receptor Mechanisms and Signaling (3 papers). The work is most often cited by research in Pharmacology (1.3k citations), Cellular and Molecular Neuroscience (659 citations), Toxicology (69 citations), Endocrine and Autonomic Systems (116 citations) and Biological Psychiatry (35 citations). Thomas Elebring has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Peter J. Greasley, Erik Ryberg, Niklas Larsson, Stephan Hjorth, S. Sjögren, Tomáš Drmota, Peter M Nilsson, Sverker von Unge, Henrik Toft Sørensen and Lanna Li. Their work appears in journals such as Journal of Medicinal Chemistry, British Journal of Pharmacology, The Journal of Organic Chemistry, Drug Discovery Today and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.